Drug-eluting versus bare metal stents in patients with ST-segment-elevation myocardial infarction: Eight-month follow-up in the drug elution and distal protection in acute myocardial infarction (DEDICATION) trial

Circulation

Volumn 118, Issue 11, 2008, Pages 1155-1162

  Kelbæk, Henning ^a,c   Thuesen, Leif ^b   Helqvist, Steffen ^a   Clemmensen, Peter ^a   Kløvgaard, Lene ^a   Kaltoft, Anne ^b   Andersen, Bente ^a   Thuesen, Helle ^b   Engstrøm, Thomas ^a   Bøtker, Hans E ^b   Saunamäki, Kari ^a   Krusell, Lars R ^b   Jørgensen, Erik ^a   Hansen, Hans Henrik T ^a   Christiansen, Evald H ^b   Ravkilde, Jan ^b   Køber, Lars ^a   Kofoed, Klaus F ^a   Terkelsen, Christian J ^b   Lassen, Jens F ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

Angioplasty; Coronary disease; Myocardial infarction; Restenosis; Stents

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; COBALT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PACLITAXEL; RAPAMYCIN; STAINLESS STEEL; ZOTAROLIMUS;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; GUIDE WIRE; HEART CATHETERIZATION; HEART DEATH; HEART INFARCTION SIZE; HEART MUSCLE REVASCULARIZATION; HEART PROTECTION; HUMAN; INTIMA; MAJOR CLINICAL STUDY; MALE; OBESITY; PERCUTANEOUS CORONARY INTERVENTION; PREMEDICATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RESTENOSIS; ST SEGMENT ELEVATION; STENT THROMBOSIS; TREATMENT DURATION; TREATMENT OUTCOME; CELL PROLIFERATION; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DEATH; HEART INFARCTION; MORTALITY; RADIOGRAPHY; STANDARD; STENT; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CELL PROLIFERATION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; DEATH; DRUG-ELUTING STENTS; FOLLOW-UP STUDIES; HUMANS; MYOCARDIAL INFARCTION; STENTS; THROMBOSIS; TREATMENT OUTCOME; TUNICA INTIMA;

EID: 54049142045     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.758698     Document Type: Article

References (25)

1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13-20.
2. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbæk H, Thayssen P, Abildgaard U, Pedersen F, Madsen JK, Grande P, Villadsen AB, Krusell LR, Haghfelt T, Lomholt P, Husted SE, Vigholt E, Kjaergaard HK, Mortensen LS, for the DANAMI-2 Investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003;349:733-742.
3. Boersma E, for the Primary Coronary Angioplasty vs. Thrombolysis Group. Does time matter? A pooled analysis of randomised clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction. Eur Heart J. 2006;27: 779-788.
4. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, Jørgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W. Guidelines for percutaneous coronary interventions: the Task Force for Percutaneous Coronary Intervention of the European Society of Cardiology. Eur Heart J. 2005;26:804-847.
5. Valgimigli M, Percoco G, Malagutti P, Campo G, Ferrari F, Barbierie D, Cicchitelli G, McFadden EP, Merlini F, Ansani L, Guardigli G, Bettini A, Parrinello G, Boersma E, Ferrari R, for the STRATEGY Investigators. Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomised trial. JAMA. 2005;293: 2109-2117.
6. Spaulding C, Henry P, Teiger E, Beatt K, Bramucci E, Carrié D, Slama MS, Merkely B, Erglis A, Margheri M, Varenne O, Cebrian A, Stoll H-P, Snead DB, Bode C, for the TYPHOON Investigators. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med. 2006;355:1093-1104.
7. Laarman GJ, Suttorp MJ, Dirksen MT, van Heerebeek L, Kiemeneij F, Slagboom T, van der Wieken L, Tijssen JGP, Rensing BJ, Patterson M. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med. 2006;355:1105-1113.
8. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005;111:3481-3488.
9. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193-202.
10. Stone GW, Webb J, Cox DA, Brodie BR, Qureshi M, Kalynych A, Turco M, Schultheiss HP, Dulas D, Rutherford BD, Antoniucci D, Krucoff MW, Gibbons RJ, Jones D, Lansky AJ, Mehran R. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction. JAMA. 2005;293:1063-1072.
11. Schömig A, Kastrati A. Distal embolic protection in patients with acute myocardial infarction: attractive concept but no evidence of benefit. JAMA. 2005;293:1116-1118.
12. De Luca G, Suryapranata H, Stone GW, Antoniucci D, Neumann F-J, Chiariello M. Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials. Am Heart J. 2007;153:343-353.
13. Kelbæk H, Thuesen L, Helqvist S, Kløvgaard L, Jørgensen E, Aljabbari S, Saunamäki K, Krusell LR, Jensen GVH, Bøtker HE, Lassen JF, Andersen HR, Thayssen P, Galløe A, van Weert A, for the SCANDSTENT Investigators. The Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial. J Am Coll Cardiol. 2006;47:449-455.
14. van Weert A, Lesperance J, Reiber JHC. Standardization of central off-line quantitative image analysis: implications from experiences with quantitative coronary angiography. Heart Drug. 2001;1:44-51.
15. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es G-A, Steg PG, Morel M-a, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW, for the Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344-2351.
16. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE, for the SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-1323.
17. Kelbæk H, Terkelsen CT, Helqvist S, Lassen JF, Clemmensen P, Kløvgaard L, Kaltoft A, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Hansen H-HT, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Thuesen L. Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial. J Am Coll Cardiol. 2008;51: 889-905.
18. Menichelli M, Parma A, Pucci E, Fiorilli R, De Felice F, Nazzaro M, Giulivi A, Alborino D, Azzellino A, Violini R. Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI). J Am Coll Cardiol. 2007;49:1924-1930.
19. Hong MK, Mintz GS, Lee CW, Park DW, Park KM, Lee BK, Kim YH, Song JM, Han KH, Kang DH, Cheong SS, Song JK, Kim JJ, Park SW, Park SJ. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation. 2006;113:414-419.
20. Grines CL, Cox DA, Stone GW, Garcia E, Mattos LA, Giambartolomei A, Brodie BR, Madonna O, Eijgelshoven M, Lansky AJ, O'Neill WW, Morice MC. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med. 1999; 341:1949-1956.
21. Maillard L, Hamon M, Khalife K, Steg PG, Beygui F, Guermonprez JL, Spaulding CM, Boulenc JM, Lipiecki J, Lafont A, Brunel P, Grollier G, Koning R, Coste P, Favereaux X, Lancelin B, Van Belle E, Serruys P, Monassier JP, Raynaud P. A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2000;35:1729-1736.
22. Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Gauigliumi G, Stuckey T, Turco M, Caroll JD, Rutherfor BD, Lansky AJ, for the CADILLAC Investigators. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med. 2002;346:957-966.
23. Sianos G, Papafaklis MI, Daemen J, Vaina S, van Mieghem CA, van Domburg RT, Michalis LK, Serruys PW. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. J Am Coll Cardiol. 2007;50:573-583.
24. Spertus JA, Kettelkamp R, Vance C, Decker C, Jones PG, Rumsfeld JS, Messenger JC, Khanal S, Peterson ED, Bach RG, Krumholz HM, Cohen DJ. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement. Circulation. 2006;113:2803-2809.
25. Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, Kramer JM, Harrington RA, Matchar DB, Kandzari DE, Peterson ED, Schulman KA, Califf RM. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA. 2007;297:159-168.